Formulation of the 2026 h share award scheme; and (2) amendments to the articles of association
Filed with HKEX · Stock code 6872 · · 3 pages · English
(1) FORMULATION OF THE 2026 H SHARE AWARD SCHEME; AND (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION The board of directors (the “Board”) of TenNor Therapeutics (Suzhou) Limited (the “Company”, together with its subsidiaries, the “Group”) hereby announces that on 21 September 2026, the Board resolved to formulate the 2026 H share award scheme (the “H Share Scheme”) and to amend the Articles of Asso
TenNor Therapeutics Suzhou Ltd. on 6ix
Earlier from TenNor Therapeutics Suzhou
Later from TenNor Therapeutics Suzhou
- 2026 Interim report
- Circular of 2026 second extraordinary general meeting
- Notice of 2026 second extraordinary general meeting
- Form of proxy for 2026 second extraordinary general meeting to be held on October 23, 2026
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow TenNor Therapeutics Suzhou into a list and get an email when it puts out news.
Follow TenNor Therapeutics Suzhou